Q'Apel Medical, a California-based private medical device company focused on neurovascular interventions, announced on Monday that it has named Jodie Fam as its new chief executive officer.
Fam succeeds R King Nelson, who retires after heading the firm for last five years and is to continue to work on the company's board of directors.
Fam has more than two decades of experience in the medical device industry. She has served in executive leadership positions at multiple medical device companies including public and several venture-backed start-ups. She has worked as Q'Apel's chief marketing officer and general manager for the company's international business. She has also worked as the CEO of AblaCare (now May Health) and in senior management positions at Route 92 Medical, Medina Medical (acquired by Medtronic), CardioKinetix and Concentric Medical (acquired by Stryker). She has served in senior clinical, sales and marketing positions with Guidant Corporation, Johnson & Johnson and Mallinckrodt Medical.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar